Skip to main content
. Author manuscript; available in PMC: 2020 Feb 27.
Published in final edited form as: Surg Obes Relat Dis. 2019 Feb 1;15(5):739–748. doi: 10.1016/j.soard.2019.01.008

Table 3:

Associations between mental disorders and psychiatric medication use with long-term weight change following Roux-en-Y gastric bypass.

Long-term pre-to post-surgery weight change
B (95% CI)a DF P
Any mood disorder (Ref=no history) 0.61
 Pre-surgery history only 0.11 (−4.67,4.89) 115
 Post-surgery 1.87 (−2.46,6.20) 109
Any eating disorder (Ref=no history) 0.97
 Pre-surgery history or post-surgery 0.12 (−6.46,6.69) 61.5
Any psychiatric medication (Ref=no useb) 0.22
 Pre-surgery only −1.22 (−9.78,7.33) 127
 Post-surgery −4.13 (−9.00,0.73) 104
a

Estimated percentage of pre-surgery weight, in years 4–7 associated with the indicated psychiatric variables, after adjustment for the other psychiatric variables, pre-surgery factors related to missing follow-up data (i.e. site and age), and sex, race, and body mass index at pre-surgery, with time entered as a fixed effect. A negative value indicates weight loss. When mood disorder was replaced by anxiety disorder, the estimates (95% CI) were 0.64 (−4.17–5.44) for pre-surgery history only and 2.17 (−2.05–6.40) for post-surgery (p= 0.56). N=72 of 104 RYGB participants.

b

Based on current medication use at pre- and post-surgery assessments. Pre-surgery history of medication use not measured.